Friday, June 05, 2020 2:17:02 PM
Outstanding Shares
43,271,310
02/10/2020
20 million shares are in cert form and will be cancelled shortly.
New O/S will only be 23 mil.
Float around 5 mil.
I have been searching for a psilocybin (mushroom) medical stock. I came across several and right now I like this one as a buy/hold type play. There is a new podcast that was released this morning. I think this sector is still very under the radar and untapped. There aren’t that many public trading stocks in this sector. This company has several divisions including CBD. After doing a quick research on the CEO, I believe he has strong credentials in the sector and the overall area of medical science.
Filings to get current any day as well as name change has been submitted.
Last PR - https://www.otcmarkets.com/stock/WUHN/news/story?e&id=1617362
06/01/2020 New CEO Interview…
https://ashi-capital.webnode.com/l/jeff-robinson/
There is a new podcast that hit recently…
https://www.smallcapvoice.com/5-22-2020-smallcapvoice-interview-with-wuhan-general-group-inc-wuhn/
Here is a seeking alpha story that mentions the sector…
Psychedelic Medicine Stocks Capture The Attention Of Investors
https://seekingalpha.com/article/4330293-psychedelic-medicine-stocks-capture-attention-of-investors?utm_source=otcmarkets&utm_medium=referral
The company web site…
https://wuhn.org/
Wuhan General Group is a Nevada state public incorporation trading on the Over The Counter Bulletin Board of NASDAQ under the trading symbol “WUHN”.
The Company is currently positioning itself to become a major player in the 146.4 billion dollars growing medical CBD (cannabidiol) space as well as the promising psilocybin medical health sector. Our mission is to advance botanical-based medicine to the forefront by deploying best practice science and medicine, clinical research and emerging technologies. has entered CBD by-product market.
Wuhan General Group through its wholly-owned subsidiary MJ MedTech, a nutraceutical company that researches, develops and commercializes a range of CBD-based products is launching of its premium CBD product lines which includes the CBD cosmetics line and the CBD coffee line in pharmacies, convenience stores and hotels across South Africa. The products are branded under the trademarks: DrAnnaRx™ and Medspresso™ respectively.
In addition, its new division, M2BIO aims to explore and develop additional indications for psilocybin new therapies that will help patients who suffer from mental illness. Wuhan has been researching multiple medicinal mushroom types in order to formulate its upcoming range of cosmetics, coffee, and teas for commercialization in early Q1 of 2020 within its M2Bio division.
The Company, with its multiple partnerships with Cape Town-based manufacturer and merchandiser of premium health products to all pharmacy & health shop chains across South Africa, will be launch Dr. AnnaRx and Medspresso products and distribute in 1000 stores and pharmacies in South Africa and adjacent countries. Our next phase is to go international: US, Canada, and Europe.
M2BIO is a division of MJ Medtech that aims to help take psilocybin-based medicine to the forefront by deploying solid medicine, commercial products, and clinical research. Work is being done to further understand the implications of psilocybin use in a number of disease states. Certain mental health disease states and symptoms have been studied, including depressed mood, anxiety disorders, obsessive-compulsive disorder, alcohol abuse, and tobacco abuse. M2BIO is currently doing an in-depth review of studies performed and their results for each of these conditions and evaluating the clinical potential for use.
Our Team..
https://wuhn.org/our-team/
The ceo has a strong following on twitter and is also on facebook so you can do your own due diligence if you choose to.
https://twitter.com/contrariansmind
https://www.facebook.com/Contrariansmind
Former Co-Founder / Partner at KwitCase
Worked at QuickMony
Former Former CEO & Founder at Global Internet Startups
Worked at IESE Business School
Former Adjunct Professor at Barcelona College of Chiropractic
Former CEO & Founder at Cookee Corporation
Studied Economics at York University
Went to Toronto French School
Lives in Barcelona, Spain
From Toronto, Ontario
Followed by 2,390 people
wuhn.org/mj-medtech
twitter.com/contrariansmind
internetbullreport.com
quora.com/Jeff-Robinson
linkedin.com/in/jeffrobinsonibr
about.me/jeffreyrobinson
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM